Abel Akara Ticha, Global Health Advocacy Incubator
7 episodes
4 weeks ago
Zambia is facing a critical immunization gap. Coverage for children under one has plummeted from approximately 84% in 2021 to just 64% in 2023, leaving many of the 700,000 babies born annually vulnerable. This decline is happening as the country faces a stark financial reality: a transition from Gavi support which requires it to increase its co-payment for critical vaccines as per its agreement with Gavi from the outset, and projected general annual vaccine costs approaching $35 m...
All content for One Shot, Long Life! is the property of Abel Akara Ticha, Global Health Advocacy Incubator and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Zambia is facing a critical immunization gap. Coverage for children under one has plummeted from approximately 84% in 2021 to just 64% in 2023, leaving many of the 700,000 babies born annually vulnerable. This decline is happening as the country faces a stark financial reality: a transition from Gavi support which requires it to increase its co-payment for critical vaccines as per its agreement with Gavi from the outset, and projected general annual vaccine costs approaching $35 m...
Kenya faces a critical crossroads in its immunization journey. Despite last financial year’s health budget of 127 billion shillings (nearly $1 billion USD), the country experienced vaccine stockouts in 12 counties in April 2025, forcing some desperate parents to travel across borders for routine childhood vaccines. In this episode of "One Shot, Long Life!" host Abel Akara Ticha uncovers the systemic challenges threatening Kenya's immunization program with two influential voices: Hon. Ja...
One Shot, Long Life!
Zambia is facing a critical immunization gap. Coverage for children under one has plummeted from approximately 84% in 2021 to just 64% in 2023, leaving many of the 700,000 babies born annually vulnerable. This decline is happening as the country faces a stark financial reality: a transition from Gavi support which requires it to increase its co-payment for critical vaccines as per its agreement with Gavi from the outset, and projected general annual vaccine costs approaching $35 m...
